XML 53 R38.htm IDEA: XBRL DOCUMENT v3.7.0.1
Share-Based Compensation (Tables)
9 Months Ended
Mar. 31, 2017
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]  
Schedule of Share-based Compensation, Restricted Stock and Restricted Stock Units Activity
The following table summarizes restricted stock activity for the nine months ended March 31, 2017:
Outstanding and Nonvested Restricted Stock Awards:
 
Shares
Awarded
 
Weighted
Average
Grant Date
Fair Value
($)
 
Weighted
Average
Remaining
Life
(Years)
 
Aggregate
Intrinsic
Value
($ in thousands)
Outstanding at June 30, 2016
 
23,792

 
26.00

 
1.8
 
763

Granted
 
5,106

 
35.25

 
0.7
 
180

Exercised/Released
 
(7,458
)
 
24.16

 
 
253

Cancelled/Forfeited
 
(5,995
)
 

 
 

Outstanding at March 31, 2017
 
15,445

 
29.79

 
1.1
 
546

Expected to vest at March 31, 2017
 
14,843

 
29.78

 
1.1
 
525

NQOs | Vested  
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]  
Schedule of Share-based Compensation, Stock Options, Activity
The following table summarizes NQO activity for the nine months ended March 31, 2017:
Outstanding NQOs:
 
Number
of NQOs
 
Weighted
Average
Exercise
Price ($)
 
Weighted
Average
Grant Date
Fair Value ($)
 
Weighted
Average
Remaining
Life
(Years)
 
Aggregate
Intrinsic
Value
($ in thousands)
Outstanding at June 30, 2016
 
219,629

 
13.87
 
6.28
 
3.7
 
3,995

Granted
 

 
 
 
 

Exercised
 
(58,324
)
 
10.72
 
4.88
 
 
1,306

Cancelled/Forfeited
 
(18,156
)
 
25.12
 
10.89
 
 

Outstanding at March 31, 2017
 
143,149

 
13.72
 
6.26
 
2.7
 
3,096

Vested and exercisable at March 31, 2017
 
129,866

 
12.40
 
5.75
 
2.4
 
2,981

Vested and expected to vest at March 31, 2017
 
142,626

 
13.67
 
6.24
 
2.7
 
3,092

PNQs  
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]  
Schedule of Share-based Payment Award, Stock Options, Valuation Assumptions
Following are the weighted average assumptions used in the Black-Scholes valuation model for PNQs granted during the nine months ended March 31, 2017.
 
Nine Months Ended 
March 31, 2017
Weighted average fair value of PNQs
$11.42
Risk-free interest rate
1.53%
Dividend yield
—%
Average expected term
4.9 years
Expected stock price volatility
37.7%
Schedule of Share-based Compensation, Stock Options, Activity
The following table summarizes PNQ activity for the nine months ended March 31, 2017:
Outstanding PNQs:
 
Number
of
PNQs
 
Weighted
Average
Exercise
Price ($)
 
Weighted
Average
Grant Date
Fair Value ($)
 
Weighted
Average
Remaining
Life
(Years)
 
Aggregate
Intrinsic
Value
($ in 
thousands)
Outstanding at June 30, 2016
 
288,599

 
25.83
 
10.82
 
5.7
 
1,798

Granted
 
149,223

 
32.85
 
11.42
 
4.8
 

Exercised
 
(8,132
)
 
24.35
 
10.67
 
 
73

Cancelled/Forfeited
 
(62,262
)
 
31.43
 
11.38
 
 

Outstanding at March 31, 2017
 
367,428

 
27.77
 
10.97
 
5.3
 
2,787

Vested and exercisable at March 31, 2017
 
149,777

 
24.01
 
10.62
 
4.3
 
1,698

Vested and expected to vest at March 31, 2017
 
353,920

 
27.64
 
10.96
 
5.3
 
2,729